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Abstract
 .Monoclonal nonspecific suppressor factor MNSF , a lymphokine produced by a murine hybridoma, was originally found
to inhibit the generation of LPS-induced immunoglobulin secreting cells. MNSF comprises of MNSFb, an isoform of
 .MNSF, and the other isoform, MNSFa . Ubiquitin-like segment Ubi-L of MNSFb shows MNSF-like activity. Ubi-L
 . 1257.8 kDa has 36% homology with 8.5 kDa ubiquitin. GST–Ubi-L was labeled with I by the chloramine T method and
tested for its conjugation to acceptor proteins in splenocyte lysates. 125I–GST–Ubi-L conjugation on SDS–PAGE showed
heterogeneous bands including 95 kDa GST–Ubi-L conjugation in the splenocyte, but not reticulocyte lysates. The Ubi-L
 .adduct appeared to be MNSF-related molecule because anti-MNSF monoclonal antibody mAb recognized the 95 kDa
band. The pattern of the conjugations was different from that seen in ubiquitination. Unlabeled GST–Ubi-L inhibited the
conjugations, while ubiquitin did not. a-Lactalbumin, one of the target proteins for ubiquitination, failed to conjugate to
GST–Ubi-L. In addition, covalent conjugation of ubiquitin to reticulocyte lysates was also interfered by GST–Ubi-L. These
results suggest that Ubi-L may conjugate to acceptor proteins in a similar, but not in the same way as ubiquitination, and
might play an important role in lymphoid cells. q 1998 Elsevier Science B.V.
Keywords: Ubiquitin-like protein; Ubiquitin; Conjugation
1. Introduction
Ubiquitin is one of the most highly conserved
proteins in all eukaryotic cells, which is small M sr
.8500 76-amino acid protein, plays an important role
in the degradation of abnormal, misfolded or improp-
w xerly assembled proteins 1,2 . The process is accom-
plished through a unique post-translational modifica-
Abbreviations: MNSF: monoclonal nonspecific suppressor
factor; rUbi-L: recombinant ubiquitin-like protein
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tion in which the carboxyl terminus Gly–Gly is
covalently ligated to primary amines on target intra-
w xcellular proteins 3 . A major consequence of ubiqui-
tin conjugation is the targeting of proteins for degra-
w xdation via multi-enzymes 4–6 , ubiquitin activating
 .  .enzyme E1 , ubiquitin conjugating enzyme E2 ,
 .protein ligase E3 , by ATP-dependent pathway re-
w xquiring the 26S protease complex 7 . The carboxyl
terminus Gly–Gly is also conserved in ubiquitin
 .cross-reactive protein UCRP which is induced by
w xinterferons 8,9 . UCRP conjugates to cellular pro-
w xteins within interferon-responsive cells 10,11 . As
recombinant human UCRP is not inhibited its conju-
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gation by ubiquitin, the mode of action of UCRP
conjugation is apparently distinct to that of ubiquitin
w x12 .
Although several soluble factors with antigen-non-
specific suppressive activity in the immune responses
have been reported, the genes that encode them have
not been clearly defined. Some factors are known to
be associated to another protein. The monoclonal
 .nonspecific suppressor factor MNSF , a product of
 .concanavalin A Con A stimulated murine T cell
hybridoma, inhibits the generation of LPS-induced
immunoglobulin secreting cells, proliferation of mito-
gen activated T and B cells and division in various
w xtumor cell lines of murine origin 13–16 . Like UCRP,
interferon gamma is involved in the mechanism of
w xaction of MNSF 14 .
Recently we have isolated and cloned the sequence
w xof MNSFb 17 , an isoform of MNSF, and the re-
 .combinant form of the ubiquitin-like segment rUbi-L
w xof MNSFb has an MNSF-like activity 15,18 . rUbi-L,
a 8.5 kDa ubiquitin like polypeptide, has 36% homol-
ogy to ubiquitin and possesses the carboxyl terminal
w xGly–Gly doublet 17 . Since Ubi-L may associate to
w xthe other subunit before extracellular release 17 , we
studied whether Ubi-L conjugates to some target
 .protein s in murine splenocyte lysate, and compared
the mechanism of Ubi-L conjugation with ubiquitina-
tion process.
2. Materials and methods
2.1. Animals
Female BALBrc mice, 8 to 16 weeks of age, were
used throughout this study and were obtained from
 .Clea Japan Osaka . The Japanese White rabbits and
the mice were reared in the Laboratory of Institute
for Experimental Animals, Shimane Medical Univer-
sity.
2.2. Materials
Bovine ubiquitin, bovine a-lactalbumin, bovine
serum albumin, aprotinin, leupeptin, prestained
molecular weight standard mixture were purchased
 .from Sigma St. Louis, MO . Phenylmethanesulfonyl
 . X fluoride PMSF , EGTA, EDTA, 5,5 -dithiobis 2-
.  .nitrobenzoic acid DTNB were purchased from
 .Wako Pure Chemical Industries, Dithiothreitol DTT
was purchased from Nakalai Tesque, Kyoto, Japan.
Molecular standard marker Low molecular weight
.calibration kit for electrophoresis was obtained from
 .Pharmacia Biotech. DEAE-cellulose DE52 was from
Whatman.
2.3. Purification of recombinant GST–Ubi-L and ra-
dio-iodination of the proteins
 .Murine recombinant Ubi-L rGST–Ubi-L was ex-
pressed in Escherichia coli and purified, as described
w xpreviously 18 except for the cleavage with throm-
bin. Briefly, rUbi-L was expressed as a fusion protein
with glutathione-S-transferase using the pGEX-2T
 .vector Pharmacia, Uppsala, Sweden , extracted and
 .purified by Glutathione Sepharose 4B Pharmacia .
rGST–Ubi-L was applied to an anion exchange col-
 .umn DEAE 5PWrTSK gel equilibrated in 50 mM
Tris-HCl, pH 7.5, and eluted with an increasing
concentration of NaCl. rGST–Ubi-L was eluted at
300 mM NaCl and its purity was more than 95%.
The purified GST–Ubi-L, ubiquitin, bovine a-
lactalbumin were labeled with 125I by the chloramine
w xT method, as described previously 19 .
2.4. Antibodies
Specific antibody against synthetic peptides corre-
 .sponding to the ubiquitin-like region PU-1 was
raised in rabbits, and the anti-PU1 Ab was coupled to
 .Sepharose 4B Pharmacia as described previously
w x  .17 . An anti-MNSF monoclonal antibody MO6 was
w xpurified as described previously 14 .
2.5. Preparation of murine and rabbit reticulocyte
lysates
Reticulocyte rich blood was obtained by phenylhy-
drazine induction of adult female rabbits and mice
w x20 . Reticulocytosis was more than 85%. To deplete
endogenous ATP reticulocyte rich blood was washed
twice with cold phosphate-buffered saline PBS;
.150 mM NaCl, 10 mM sodium phosphate, pH 7.4
and incubated at 378C for 90 min with the addition of
20 mM 2-deoxyglucose and 0.2 mM 2,4-dinitrophenol
w x21 . Subsequently, the cells were washed with PBS,
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lysed in a solution A; containing 1 mM DTT, 1 mM
EDTA, 1 mM EGTA, 1 mM PMSF, and 1 mM leu-
peptin. The particulate fraction was removed by cen-
 .trifugation 40 000=g, 60 min , and the supernatant
was harvested, and stored at y808C until use.
2.6. Preparation of murine splenocyte lysates
Single cell suspension of spleen was prepared,
washed twice with cold PBS and lysed in solution A.
Particulate fraction was removed by centrifugation
 .40 000=g, 60 min . In some experiments, spleno-
 7 .cytes 1.2=10 cellsrml were incubated with Con
 .A 3 mgrml for 48 h. The activated cells were lysed
in the solution A.
2.7. Preparation of Ubi-L depleted lysates
To deplete endogenous Ubi-L, cell lysates in PBS
were subjected to anti-PU-1 antibody coupled to
Sepharose 4B and incubated at 48C for overnight, and
the unbound fraction was harvested.
2.8. Fractionation of cell lysates
 .Fraction 1 proteins unbound to DE52 and frac-
 .tion 2 bound to DE52 and eluted with 0.5 M KCl
were prepared from rabbit and murine reticulocytes,
w xand murine splenocyte lysate 21 . Protein concentra-
tions in the lysates were determined by the Bradfold
 .assay Bio-Rad .
All the lysates including both fractions were dia-
lyzed twice against reaction buffer 50 mM Tris-HCl,
.pH 7.5, 0.2 mM DTT, 1 mM PMSF by Centricon-10
 .Amicon , and protein concentrations were prepared
within 5–10 mgrml in splenocyte lysates, 20–
30 mgrml for reticulocyte lysates, respectively. All
the lysates could be stored at y808C for over a year
without loss of activity.
2.9. Construction and incubation of the conjugation
reaction mixture
 .The standard incubation mixture 20 ml contained
50 mM Tris-HCl, pH 7.5, 0.2 mM DTT, 1 mM PMSF,
20–30 mg of lysate proteins, 0.5 mgrml carrier
bovine serum albumin and approximately 40 000 cpm
125  6 . w xof I-labeled protein 10 cpmrmg 19 . Reaction
mixtures were incubated at 378C for indicated peri-
ods, subsequently quenched by the addition of 2=
 .SDS sample buffer Laemmli containing b-mer-
captoethanol, and dissolved by 10% or 15% SDS
polyacrylamide gel. Detection of 125I-labeled GST–
Ubi-L protein conjugates was determined by the
SDS–PAGE after 16 h incubation. The conjugation
of ubiquitin to reticulocyte lysates, a-lactalbumin,
and ubiquitin was determined after 15 min incubation.
Conjugated proteins were visualized by autoradiog-
raphy of the dried gel. The region of the gel contain-
ing the conjugates was excised and estimated by
 .Bio-Imaging analyzer BAS-2000II Fuji Photo Film,
 .and Ultroscan XL enhanced laser densitometer LKB .
2.10. Immunoblotting
 .The reaction mixture 60 ml contained 50 mM
Tris-HCl, pH 7.5, 0.2 mM DTT, 1 mM PMSF, 100 mg
of unstimulated splenocyte lysates and approximately
2 pmoles of unlabeled GST–Ubi-L, after 6 h incuba-
tion at 378C and the resultants were resolved in 10%
polyacrylamide gels under reducing conditions. The
gels were transferred to enhanced chemiluminescence
 .ECL Hybond membranes, following which
immunostaining was performed. MO6, a murine
w xmonoclonal antibody to native MNSF 14 , was used
Fig. 1. Conjugation of 125I–GST–Ubi-L to acceptor proteins in
 .splenocyte lysates. The reaction mixtures 20 ml including vari-
ous cell lysates, 50 mM Tris-HCl, pH 7.5, 0.2 mM DTT, 1 mM
PMSF and 1 pmole of 125I–GST–Ubi-L were incubated for 16 h
at 378C and then quenched with SDS sample buffer. Lane 1: in
the absence of cell lysates; lane 2: containing 30 mg of crude
splenic cell lysates; lane 3: 30 mg of murine spleen f1; lane 4:
30 mg of f2; lane 5: 30 mg each of f1 and f2; lane 6, 60 mg of
crude lysates. Lane 1: for the control experiments, 125I–GST–
Ubi-L was added after quenching with SDS sample buffer.
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Fig. 2. Time course and dose dependence of 125I–GST–Ubi-L
conjugation, Panel A: Indicated amounts of splenic cell lysates
were incubated at 378C for 16 h with 125I–GST–Ubi-L in a 20 ml
volume of reaction mixture and quenched by SDS sample buffer.
Lane 1: no addition of lysates; lane 2: 5mg; lane 3: 12.5mg;
lane4: 25mg; lane 5: 50 mg; lane 6: 75mg; lane 7: 90 mg. Panel
B: 25mg of cell extracts and 125I–GST–Ubi-L were incubated at
378C for indicated period and then quenched with SDS sample
buffer. Lane 1: no addition of extracts; lane 2: 0 min; lane 3:
30 min; lane 4: 90 min; lane 5: 4 h; lane 6: 16 h.
for a first antibody and biotinylated anti-mouse IgG
antibody for a second antibody. Peroxidase-con-
jugated streptavidin was used for the last step. Detec-
tion was done according to the ECL system
 .Amersham .
3. Results
3.1. Conjugation of 125I-GST–Ubi-L to intracellular
proteins
We speculated that Ubi-L conjugates to some pro-
teins in splenic cells, because a specific Ab to Ubi-L
immunoprecipitates several proteins from mouse
w xsplenocyte lysates 17 . This notion is supported by
the fact that the amino acid sequences considered
important for the ubiquitination process are con-
served in Ubi-L, including the carboxyl terminal
 .Gly–Gly doublet. Recombinant Ubi-L rUbi-L tends
to form self-aggregation due to its strong hydropho-
w xbicity 17 . Thus, in this study, we employed GST–
Ubi-L to investigate whether or not Ubi-L actually
conjugates to intracellular proteins. This fusion pro-
tein is stable in terms of aggregative and adsorptive
characteristics, as compared with rUbi-L. It should be
noted that GST–ubiquitin substitutes functionally for
w xauthentic ubiquitin in ligation to substrates 22 .
GST–Ubi-L was radiolabeled by the method of
chloramine T as described under Section 2. It is
possible that the tyrosine residues of GST were radio-
labeled with 125I, because Ubi-L lacks the aromatic
w x 125  .amino acid 17 . I-GST–Ubi-L 1 pmole was incu-
 .bated with murine splenocyte lysates 30 mgr20 ml
for 16 h at 378C. Although a strong conjugate band
was developed within 4 h, longer incubation was
performed to accomplish the conjugation. Subse-
quently, the reaction mixtures were resolved in 10%
polyacrylamide gels. Heterogeneous bands were ob-
 . 125served Fig. 1, lanes 2 and 6 , suggesting that I-
GST–Ubi-L conjugates to some intracellular proteins
in the lysates. 125I-GST did not conjugate to any
 .proteins in the splenocyte lysates data not shown .
Ubiquitin conjugates to murine reticulocyte and
Fig. 3. Inhibition of Ubi-L conjugation. 125I–GST–Ubi-L was
incubated with splenic cell lysates which had been depleted of
endogenous Ubi-L as described under Section 2. Lane 1: in the
absence of Ubi-L depleted lysates; lane 2: in the presence of the
 .lysates 25mg ; lane 3: the same to lane 2 but a 100 fold excess
amount of unlabeled GST–Ubi-L was added; lane 4: the same to
lane 2 but a 100 fold amount of ubiquitin added.
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splenocyte lysates in the presence of 2 mM ATP data
.not shown . In contrast with ubiquitination, Ubi-L
conjugations occurred in the absence of added ATP.
The pattern of the conjugation was same in the
presence of 2 mM ATP. Interestingly, 125I-GST–Ubi-
L did not associate with any proteins in murine
reticulocyte lysates, presumably due to a lack of
target proteins andror enzymes involving in the Ubi-
L conjugation. To determine the optimal condition
for Ubi-L conjugation, 125I-GST–Ubi-L was incu-
  ..bated with several amounts of lysates Fig. 2 A for
  ..various periods Fig. 2 B . The concentration of
25mgr20 ml resulted in a maximal conjugation and
was therefore used in the following experiments. We
also observed that conjugation was completed after
16 h.
Fig. 4. The influence of DTT and DTNB upon Ubi-L conjugation. Panel A: 125I–GST–Ubi-L was incubated with splenocyte lysates
 .25mg in the presence of various amounts of DTT. Lane 1: in the absence of lysates and DTT; lane 2: in the absence of DTT; lane 3:
0.2 mM DTT; lane 4: 2 mM; lane 5: 5 mM; lane 6: 10 mM; 7, 15 mM; 8, 20 mM. Relative intensity of 95 kDa band estimated by the
imaging analyzer was also presented. Panel B: 125I–GST-Ubi-L was incubated with splenic cell lysates in the presence of DTNB. Lane 1:
in the absence of lysates; lane 2: 25mg of lysates; lane 3: 25mg lysates and 0.5 mM DTNB. NS indicates nonspecific band.
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Fig. 5. Ubi-L conjugation in Con A stimulated splenocyte lysates.
125I–GST–Ubi-L was incubated with unstimulated or Con A
 .48 h - stimulated splenocyte lysates. Lane: 1, in the absence of
cell lysates; lane 2: 20 mg of unstimulated cell lysates; lane 3:
30 mg of the cell lysates; lane 4: 30 mg of Con A-stimulated
splenocyte lysates.
The reaction proceeded very slowly and the amount
of Ubi-L conjugations was lesser than that of ubiqui-
tination. The splenocyte lysates were fractionated by
 .anion exchange chromatography DE52 into fraction
 . 1 f1, flow through and fraction 2 f2, 0.5 M KCl
. w xeluate as described previously 21 . As shown in Fig.
1, the pattern of Ubi-L conjugation to acceptor pro-
teins in f1 was different from that seen in f2. It has
been shown that 125I-ubiquitin does not conjugate to
any proteins in f1 due to the lack of enzymes respon-
sible for ubiquitination. On the contrary, 125I-GST–
Ubi-L associated with several proteins in both the
fractions. The conjugations in f1 showed compara-
tively low molecular mass, whereas those in f2 in-
cluded a strong band migrated at the position of
approximately 95 kDa. The pattern of the conjuga-
tions in crude splenocyte lysates was similar to that
seen in the fraction reconstructed with f1 and f2
 .compare lanes 2 with 5 . Thus, it seems likely that
the acceptor proteins for Ubi-L exist in both f1 and
f2.
To demonstrate the specificity of these conjuga-
tions, we performed inhibition tests. As shown in Fig.
3, 125I-GST–Ubi-L conjugations were partly inhibited
by the addition of 100-fold unlabeled GST–Ubi-L
when Ubi-L depleted-lysates were employed as de-
scribed in Section 2. In contrast, ubiquitin did not
 .affect the GST–Ubi-L conjugations Fig. 3, lane 4 .
When crude lysates were used the GST–Ubi-L did
not affect at all presumably due to the existence of
endogenous Ubi-L in the lysates.
3.2. The effect of thiol modifying agent on GST–Ubi-L
conjugation
Since the activation of ubiquitin is constituted by
w xE1-ubiquitin thiol formation 23 , we investigated the
effect of thiol modifying agent on Ubi-L conjuga-
tions. As expected, DTT, a disulfide reducing reagent,
abrogated the conjugations in a dose dependent man-
  .. Xner Fig. 4 A . We next investigated whether 5,5 -di-
 .  .thiobis 2-nitrobenzoic acid DTNB , a thiol modify-
ing reagent, affects the Ubi-L conjugations. DTNB
remarkably inhibited the conjugations including the
  . .95 kDa band Fig. 4 B , lane 3 , suggestive of the
involvement of thiol linkage in the Ubi-L conjuga-
tion. However, the Ubi-L adducts do not contain
disulfide bond, because these bands are stable for
boiling in the presence of 2b-mercaptoethanol.
3.3. GST–Ubi-L conjugation in mitogen acti˝ated
cell lysates
We also examined the Ubi-L conjugation in Con A
 .activated 48 h splenocyte lysates. Interestingly, the
strong band of 95 kDa Ubi-L adduct was decreased
 .  .approximately 80% Fig. 5, lane 4 . Calculative
molecular mass of GST–MNSF is approximately
95 kDa, because the masses of GST and MNSF are
25 kDa and 70 kDa, respectively. To determine
Fig. 6. Immunoblot analysis of 95 kDa molecule. In vitro conju-
gation and immunoblot analysis were performed as described in
Section 2. Lane 1: hybridoma derived native 70 kDa MNSF; lane
2: GST–Ubi-L alone; lane 3: unstimulated splenic cell lysates;
lane 4: GST–Ubi-L incubated with splenic cell lysates.
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Fig. 7. Inhibition of ubiquitination by Ubi-L. 125I-ubiquitin was
incubated with rabbit reticulocyte lysates for 15 min at 378C.
Lane 1: in the absence of lysates; lane 2: 20 mg; lane 3: 20 mg of
lysates and unlabeled 100-fold amount of ubiquitin; lane 4: 20 mg
of lysates and unlabeled 100-fold amount of GST–Ubi-L.
whether the 95 kDa band is MNSF-related molecule,
 .we employed a monoclonal antibody MO6 to native
w xMNSF. MO6 does not recognize Ubi-L 17 . Im-
munoblot experiments showed that MO6 did detect
 .the 95 kDa band Fig. 6, lane 4 , clearly demonstrat-
ing that the band is GST–MNSF in term of the
molecular mass and the antigenicity. There was, how-
ever, no detectable band in the lysates incubated
 .without GST–Ubi-L Fig. 6, lane 3 . One may specu-
late that the conformational change of an unidentified
w x MNSF subunit 17 the conjugation of the subunit to
Fig. 8. 125I-a-lactalbumin conjugates to ubiquitin but not to
GST–Ubi-L. 125I-a-lactalbumin was incubated with Fraction 2
 .F2 from Ubi-L depleted-murine reticulocyte lysates and ubiqui-
 .  .tin lane 3 or GST–Ubi-L lane 4 for 15 min at 378C. Lane 1:
125I-a-lactalbumin alone; lane 2: 125I-a-lactalbumin plus the
reticulocyte lysates F2. Bracket indicates the conjugated adducts.
.Ubi-L should be necessary to generate the anti-
genicity.
3.4. GST–Ubi-L affects ubiquitination
We prepared mouse reticulocytes by phenylhydra-
zine induction, since the mode of action of Ubi-L
w x 125shows species-specificity 15 . I-GST–Ubi-L did
not conjugate to any proteins in murine reticulocyte
lysates, indicative of the specificity of the Ubi-L
conjugation in splenocyte lysates. Ubiquitination to
rabbit reticulocyte lysates was inhibited by the addi-
 .tion of the unlabeled GST–Ubi-L Fig. 7, lane 3 , but
 .not by GST data not shown . Ubiquitin conjugated
to 125I-a-lactalbumin in Fraction 2 from murine Ubi-L
 .depleted-reticulocyte lysates Fig. 8, lane 3 , whereas
 .GST–Ubi-L did not Fig. 8, lane 4 , suggesting that
the acceptor proteins for Ubi-L may differ from those
for ubiquitin. Collectively, the mechanism of Ubi-L
adduct formation might be distinct from ubiquitina-
 .tion, although a common pathway s may exist.
4. Discussion
In the current study, we used splenocyte lysates for
Ubi-L conjugation experiments, because 70 kDa
MNSF, a Ubi-L adduct, has been observed in the cell
w xlysates 17 . Ubi-L conjugation to intracellular pro-
 .teins was specific and reproducible, because; i cold
GST–Ubi-L remarkably inhibited the conjugation;
 .ii GST itself did not conjugate to any proteins in the
 . 125lysates; iii I-GST–Ubi-L did not conjugate to any
 .proteins in mouse reticulocyte lysates; iv the Ubi-L
 .conjugation occurred dose- and time-dependently; v
the conjugation could not be seen when damaged
 .lysates were used not shown .
Ubiquitin is highly conserved in eukaryotic cells,
w xwhereas Ubi-L shows species specificity 15 . Ubi-L
presents more than 50% homology with ubiquitin if
.conservative amino acids are considered , and pos-
sesses Gly–Gly doublet essential for the ubiquitina-
tion. Thus, we speculate that the mechanism of Ubi-L
conjugation may be similar but not identical to ubiq-
uitination process. This notion may be supported by
the fact that GST–Ubi-L inhibited ubiquitination Fig.
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.7 , although the pattern of Ubi-L adduct formation
was quite different from that of ubiquitination.
Covalent conjugation of ubiquitin to intracellular
protein is a signal for degradation by the 26S pro-
w xtease 24,25 . Sequential action of ubiquitin conjugat-
ing enzyme forms a covalent thiol ester with ubiqui-
tin as part of its catalytic cycle. Ubiquitination typi-
cally occurs through an intermolecular enzyme-
w xubiquitin thiol ester cascade 24,26 . At least, the
activation of ubiquitin requires ATP and then the
sequential conjugation proceeds through, while
GST–Ubi-L conjugation accomplishes in the absence
of added ATP. A similar phenomenon has been
reported for extracts from green plant tissues and
w xprokaryote 27–29 . However, it is possible that cell
extracts might include a small amount of ATP. It has
been reported that many E1-like enzymes have very
low Km’s for ATP. Thus, further investigations are
 .underway in our laboratory to identify the enzyme s
involved in the Ubi-L conjugations.
In spite of the sequence homology, Ubi-L does not
 29 48have some important residues Lys , Lys and
63.Lys in ubiquitin which are critical amino acids for
w x 48multi-ubiquitin chain formation 30–32 . The Lys
of ubiquitin is responsible for ATP dependent degra-
dation and Arg74 represents a major contribution in
the initial binding of the polypeptide to E1. These
amino acids are replaced with Ser 46 and Leu72, re-
spectively, in the Ubi-L sequence. It should be noted
that Ubi-L lacks the amino acids, Thr7 and Leu8, in
w xubiquitin 17 . Thus, it is possible that Ubi-L may be
free from the function of protein degradation. Indeed,
ubiquitin conjugated to a-lactalbumin, while Ubi-L
  ..did not Fig. 8 A . Although the ubiquitination was
inhibited by the addition of unlabeled GST–Ubi-L
  ..Figs. 7 and 8 B , the GST–Ubi-L conjugation was
 .not inhibited by excess ubiquitin Fig. 3 .
The amount of the 95 kDa Ubi-L adduct in Con
A-stimulated murine splenocyte lysates was drasti-
cally decreased. We have observed the strong expres-
 .sion of mRNA for Ubi-L in Con A stimulated 24 h
w xmurine splenocytes 17 . We also described several
 .Ubi-L conjugations in Con A stimulated 48 h
splenocytes with the use of a specific antibody to
Ubi-L. The strong 70 kDa band was observed in both
cultured cell lysates and conditioned media. Thus, we
conceive that the low level of Ubi-L conjugation
within the Con A-activated cells may be due to the
result of the extracellular release of 70 kDa MNSF,
the Ubi-L adduct. Another possibility is that the
increase of the intracellular Ubi-L might compete
with 125I-GST–Ubi-L, because notable augmentation
of Ubi-L mRNA is evident in Con A-activated
splenocytes, as described above.
We have reported that the products of MNSFb
cDNA may be cleaved in the cytoplasm, as has been
demonstrated for the rat Fau protein in reticulocyte
w xlysates 33 , and only the ubiquitin-like segment
 .  .7.8 kDa associated with other protein s is released
as a complex of higher molecular mass 70 kDa
. w xMNSF 17 . In the immunoprecipitation experi-
ments, several bands including the 70 kDa MNSF
were observed in mouse splenocyte lysates. Judging
from the molecular mass, the 95 kDa protein ap-
peared to be GST–MNSF. We confirmed that the
 .95 kDa band is GST–MNSF Fig. 6 , with the use of
 .a monoclonal antibody to MNSF MO6 , which does
not react with Ubi-L.
The Ubi-L conjugation was affected by thiol modi-
fying reagents DTNB and DTT. Ubi-L possesses one
cysteine residue at the position of 57. These thiol
modifying reagents also affect the activity of glyco-
 . w xsylation inhibitory factor GIF 34 , a cytokine with
immunosuppressive function. Modification of inac-
 .tive human recombinant GIF hrGIF containing 3
cysteine residues with DTNB results in active form.
GIF is ubiquitously expressed and lacks a signal
w xpeptide as well as MNSF 34 . The activity of this
bioactive hrGIF and native GIF is lost by the treat-
ment with DTT. In contrast, the Ubi-L conjugation is
inhibited by the addition of DTT and DTNB.
 .Ubiquitin cross-reactive protein UCRP is also a
ubiquitin-like protein. Interestingly, this cytokine can
w xbe induced by IFNs as well as MNSF 9,10 . Viral
infection of mammalian cells also induces the expres-
sion of UCRP, as a part of the interferon response
w x9,35 . Most recently, it has been shown that another
ubiquitin-like protein, sentrin, is a nuclear protein and
conjugates to other proteins in a process analogous to
w xubiquitination 36,37 . Therefore, one may speculate
that ubiquitin-like proteins may be closely implicated
in the immune responses and that their mode of
action would be similar to ubiquitination. Further
investigations of Ubi-L conjugation are currently in
progress to clarify the underlying mechanism of ac-
tion of MNSF.
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